Biofluid Protein Segmentation for NSCLC Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current clinical tests for early detection of non-small cell lung cancer (NSCLC) have limited progress, and existing biomarker studies face challenges due to the wide range of protein concentrations in plasma, making it difficult to develop practical and effective discovery methods.
Innovation Solution
The method involves analyzing protein-particle interactions by obtaining a dataset from biomolecule coronas formed with physiochemically distinct particles incubated in biofluid samples, using a classifier to identify healthy, cancerous, or comorbid states, specifically for NSCLC, with a focus on proteins like Angiopoietin-related protein 6, Serine protease HTRA1, and others, to achieve high sensitivity and specificity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If complex biochemical workflows are used to analyze plasma proteins, then measurement precision may be improved, but device complexity and ease of operation deteriorate
Solution Approach 1:
The plasma protein analysis is segmented into distinct size-based fractions using size-exclusion chromatography. Proteins are separated by hydrodynamic radius into different elution volumes, allowing systematic analysis of specific size ranges (e.g., 5-20 nm, 20-50 nm) rather than attempting to detect all proteins simultaneously, thus simplifying the detection workflow while maintaining precision for target fractions.
Solution Approach 2:
An antibody-based enrichment step serves as an intermediary between plasma sampling and mass spectrometry detection. The antibody specifically binds to target proteins (e.g., albumin, immunoglobulins) in the plasma, concentrating them and removing interfering substances, thereby enabling precise detection without requiring complex direct analysis workflows.
2Ease of operation
If plasma samples are analyzed directly for protein biomarkers, then ease of operation is maintained, but measurement precision deteriorates due to wide concentration ranges
Solution Approach 1:
The plasma proteome is segmented by size into discrete fractions using size-exclusion chromatography. This segmentation allows the instrument to focus on specific protein size ranges where biomarkers of interest are located, avoiding the overwhelming dynamic range issue of analyzing all plasma proteins simultaneously. The method maintains operational simplicity by automating the segmentation process through standard chromatographic elution.
Solution Approach 2:
The method changes the physical parameter of protein separation from concentration-based (traditional immunodepletion) to size-based (hydrodynamic radius). By eluting proteins according to their hydrodynamic radius rather than removing them by concentration, the method preserves low-abundance biomarkers while simplifying the workflow. The elution volume serves as a proxy for protein size, enabling precision detection without complex concentration-matching procedures.
3Measurement precision
If comprehensive protein profiling is performed, then measurement precision improves, but loss of time increases
Solution Approach 1:
Size-exclusion chromatography separation is performed as a preliminary action before mass spectrometry detection. By pre-separating plasma proteins into size-based fractions, the method reduces the complexity of the subsequent MS analysis, allowing faster acquisition times while maintaining comprehensive profiling capability. The separation occurs during sample loading and initial processing, so no additional time is required beyond the standard chromatographic run.
Solution Approach 2:
The size-exclusion chromatography elution is performed continuously during the mass spectrometry acquisition process. As proteins elute from the column over time, they are directly introduced into the mass spectrometer for continuous detection. This continuous workflow eliminates the need for discrete collection and analysis steps for each protein fraction, maintaining measurement precision across the full proteome while minimizing total analysis time.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables the identification of NSCLC with a sensitivity and specificity of 80% or greater, distinguishing between early and late stages, and differentiating it from pulmonary comorbidities, thereby improving early disease detection and treatment administration.
Implementation Method 1
Interactions between biological molecules and particles and protein-protein interactions on particles may provide insights on protein-protein interactions across biological samples
Data Source
AI summary
Disclosed herein are methods and compositions for processing biofluid samples. Some such methods may include obtaining a biofluid sample from a subject having a disease state such as lung cancer. The biofluid sample may be contacted with a nanoparticles to adsorb proteins. The proteins may then be ionized or contacted with a detection reagent. Also disclosed herein are compositions comprising proteins coupled to a nanoparticle upon contact of the nanoparticle with a biofluid sample from a subject having a disease.